Medicine for treating breast cancer and its preparation method and application

Abstract

The invention discloses a medicine for treating breast cancer and its preparation method and application. The medicine is composed of 3 to 7 parts by weight of sesamol, 7 to 15 parts of diclofenac sodium, 1 to 3 parts of niacin and 11 to 19 parts of inositol. The preparation method comprises mixing sesamol, diclofenac sodium and inositol, adding deionized water of which the mass is 3.8 times that of the mixture into the mixture, carrying out microwave treatment for 8min to obtain a mixture A, mixing the mixture A and niacin, carrying out ultrasonic treatment at a temperature of 40 DEG C for 20min, and carrying out stirring at a temperature of 45 DEG C until a dry medicine is obtained. Through synergism of all the raw materials, the medicine has obvious effects of resisting breast cancer, has low toxic or side effects and has unexpected technical effects. The medicine has the advantages of simple and easily available raw materials, small dosage, high curative effect and no toxic or side effect. The medicine can be used as a breast cancer-resistant drug, can be prepared by simple processes, realizes a low cost and is suitable for large-scale promotion.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a medicine for treating breast cancer and a preparation method and application thereof. Background technique [0002] Cancer is a common and frequently-occurring disease that seriously endangers people's lives and health. Due to the different parts of cancer, there can be various types of cancers, such as breast cancer, stomach cancer, breast cancer, bone cancer, skin cancer, bowel cancer, and liver cancer. and many more. [0003] Breast cancer is a malignant tumor that occurs in the glandular epithelium of the breast. 99% of breast cancers occur in women and only 1% in men. The etiology of breast cancer is not yet fully understood. Studies have found that there is a certain regularity in the incidence of breast cancer. Women with high risk factors for breast cancer are prone to breast cancer. The so-called high-risk factors refer to various risk factors related to the incide...

AI Technical Summary

Problems solved by technology

However, studies have shown that breast cancer patients still face a higher risk of recurrence after the initial surgery, and the peak of recurrence is concentrated at about 2 years

Postoperative chemotherapy and endocrine therapy can reduce the annual mortality rate of breast cancer by about 20%, but chemotherapy, radiotherapy, and endocrine therapy often produce gastrointestinal reactions, leukopenia, hair loss and other side effects